购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Transferase
    (1)
  • Others
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (7)
筛选
搜索结果
TargetMol产品目录中 "

gba 3

"的结果
  • 抑制剂&激动剂
    3
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    1
    TargetMol | Recombinant_Protein
  • 多肽产品
    1
    TargetMol | Peptide_Products
  • 检测抗体
    5
    TargetMol | Antibody_Products
  • Ibiglustat
    Venglustat, SAR402671, GZ402671
    T44731401090-53-6
    Ibiglustat (GZ402671) 是一种可透过血脑屏障的、具有口服活性的葡萄糖神经酰胺合成酶(GCS)抑制剂。它可用于戈谢病 3 型、法布瑞氏症、与 GBA 突变相关的帕金森病、GM2 神经节苷脂病和常染色体显性多囊肾病的研究。
    • ¥ 340
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • γ-Glu-Phe
    γ-Glutamylphenylalanine
    TP10017432-24-8
    γ-Glu-Phe (γ-Glutamylphenylalanine) is a γ-3 glutamyl dipeptide found in sourdough, synthesized by Bacillus amyloliquefaciens (GBA) and Aspergillus oryzae (GAO). γ-Glu-Phe or the post-enzymatic reaction mixture enhances the umami intensity of commercial products.
    • ¥ 578
    期货
    规格
    数量
  • Ibiglustat succinate
    GZ402671succinate,Venglustat succinate,Ibiglustat succinate,SAR402671succinate
    T391051629063-80-4
    Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant inhibitor of glucosylceramide synthase (GCS). It is utilized in the investigation of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease.
    • ¥ 1180
    5日内发货
    规格
    数量